Diagnosis,Classification,and Management of Soft Tissue Sarcomas

Pisters P.W.T. , O'Sullivan B. , Demetri G.D. . Sarcomas of non osseous tissues. In: Bast R.C. Jr , Kufe D.W. , Pollock R.E. . Cancer Medicine e.5. 5th ed. Hamilton, Ont; Lewiston, NY: Decker; 2000.

Zahm S.H. , Frumeni J.F. Jr . The epidemiology of soft tissue sarcoma. Semin Oncol. 1997; 24: 504–514.

Pisters P.W. , Leung D.H. , Woodruff J. . Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcoma of the extremities. J Clin Oncol. 1996; 14: 1679–1689.

Weiss S.W. , Goldblum J.R. , eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, Pa: Mosby; 2001.

Sondak V.K. , Chang A.E. . Clinical evaluation and treatment of soft tissue tumors. In: Weiss Sw , Goldblum J.R. , eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, Pa: Mosby; 2001.

Singer S. , Corson J.M. , Gonin R. . Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg. 1994; 219: 165–173.

Greenlee R.T. , Murray T. , Bolden S. . Cancer statistics, 2000. CA Cancer J Clin. 2000; 50: 7–33.

Ariel I.M. . Tumors of the peripheral nervous system. Semin Surg Oncol. 1988; 4: 7–12.

Bauer T.W. , Estes L. . Peripheral nerve sheath tumors. In: Raaf J.H. , ed. Soft Tissue Sarcomas: Diagnosis and Treatment. St. Louis, Mo: Mosby; 1996.

Weiss S.W. . Smooth muscle tumors of soft tissue. Adv Anat Pathol. 2002; 9: 351–359.

Kraus M.D. , Guillou L. , Fletcher C.D. . Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. Am J Surg Pathol. 1997; 21: 518–527.

Farshid G. , Weiss S.W. . Massive localized lymphedema in the morbidly obese: a histologically distinct reactive lesion simulating liposarcoma. Am J Surg Pathol. 1998; 22: 1277–1283.

Lucas D.R. , Nascimento A.G. , Sanjay B.K. . Well-differentiated liposarcomas. The Mayo Clinic experience with 58 cases. Am J Clin Pathol. 1994; 102: 677–683.

Peabody T.D. , Gibbs C.P. Jr , Simon M.A. . Evaluation and taging of musculoskeletal neoplasms. J Bone Joint Surg Am. 1998; 80: 1204–1218.

Hermann G. , Abdelwahab I.F. , Miller T.T. . Tumour and tumourlike conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses. Br J Radiol. 1992; 65: 14–20.

Belal A. , Kandil A. , Allam A. . Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol. 2002; 25: 16–22.

Hatano H. , Tokumaga K. , Ogose A. . Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: neoplastic or reactive? Pathol Int. 1999; 49: 14–22.

Reid R. , Barrett A. , Hamblen D.L. . Sclerosing epithelioid fibrosarcoma. Histopathology. 1996; 28: 451–455.

Blewitt R.W. , Aparicio S.G. , Bird C.C. . Epithelioid sarcoma: a tumour of myofibroblasts. Histopathology. 1983; 7: 573–584.

Foschini M.P. , Eusebi V. . Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma? Semin Diagn Pathol. 1994; 11: 58–68.

Ordonez N.G. . Alveolar soft part sarcoma: a review and update. Adv Anat Pathol. 1999; 6: 125–139.

Chung E.B. , Enzinger F.M. . Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am J Surg Pathol. 1983; 7: 405–413.

Gupta S. , Jain S. , Sodhani P. . Alveolar soft part sarcoma: a rare entity with unique cytomorphologic features. Cytopathology. 2003; 14: 40–41.

Nielsen G.P. , O'Connell J.X. , Wehrli B.M. . Collagen-rich tumors of soft tissues: an overview. Adv Anat Pathol. 2003; 10: 179–199.

Fletcher C.D. . Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992; 16: 213–228.

Raaf J.H. . Soft Tissue Sarcomas: Diagnosis and Treatment. St. Louis, Mo: Mosby Year Book, Inc; 1996.

Campanacci M. Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology, and Treatment. Wein: Springer-Verlag; 1999.

Mankin H.J. . A computerized system for orthopaedic oncology. Clin Orthop. 2002; 398: 252–261.

Enzinger F.M. . Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol. 1986; 10(Suppl 1): 43–53.

Weiss S.W. , Enzinger F.M. . Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978; 41: 2250–2266.

Bertoni F. , Capanna R. , Biagini R. . Malignant fibrous histiocytoma of soft tissue. An analysis of 78 cases located and deeply seated in the extremities. Cancer. 1985; 56: 356–367.

Fanburg-Smith J.C. , Spiro I.J. , Katapuram S.V. . Infiltrative subcutaneous malignant fibrous histiocytoma: a comparative study with deep malignant fibrous histiocytoma and an observation of biologic behavior. Ann Diagn Pathol. 1999; 3: 1–10.

Salo J.C. , Lewis J.J. , Woodruff J.M. . Malignant fibrous histiocytoma of the extremity. Cancer. 1999; 85: 1765–1772.

Rosenberg A.E. . Malignant fibrous histiocytoma: past, present and future. Skeletal Radiol. 2003; 32: 613–618. Epub 2003 Sep 27.

Le Doussal V. , Coindre J.M. , Leroux A. . Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer. 1996; 77: 1823–1830.

Radio S.J. , Wooldridge T.N. , Linder J. . Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors. Hum Pathol. 1988; 19: 74–77.

Mehdi R. , Shimizu T. , Yoshimura Y. . Expression of bone morphogenetic protein and its receptors in osteosarcoma and malignant fibrous histiocytoma. Jpn J Clin Oncol. 2000; 30: 272–275.

Yoshikawa H. , Rettig W.J. , Lane J.M. . Immunohistochemical detection of bone morphogenetic proteins in bone and soft tissue sarcomas. Cancer. 1994; 74: 842–847.

Binder S.W. , Said J.W. , Shintaku I.P. . A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1(CD 68). Am J Clin Pathol. 1992; 97: 759–763.

Choong P.F. , Mandahl N. , Mertens F. . 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer. 1996; 16: 88–93.

Asano N. , Yamakazi T. , Seto M. . The expression and prognostic significance of bone morphogenetic protein-2 in patients with malignant fibrous histiocytoma. J Bone Joint Surg Br. 2004; 86: 607–612.

Michael R.H. , Dorfman H.D. . Malignant fibrous histiocytoma associated with bone infarcts. Clin Orthop. 1976; 118: 180–183.

Mirra J.M. , Bullough P.G. , Marcove R.C. . Malignant fibrous histiocytoma and osteosarcoma in association with bone infarcts: report of four cases, two in caisson workers. J Bone Joint Surg Am. 1974; 56: 932–940.

Keel S.B. , Jaffe K.A. , Petur Nielsen G. . Orthopedic implant-related sarcoma: a study of twelve cases. Mod Pathol. 2001; 14: 969–977.

Lucas D.R. , Miller P.R. , Mott M.P. . Arthroplasty-associated malignant fibrous histiocytoma: two case reports. Histopathology. 2001; 39: 620–628.

Oliveira A.M. , Nascimento A.G. . Pleomorphic liposarcoma. Semin Diagn Pathol. 2001; 18: 274–285.

Nascimento A.G. . Dedifferentiated liposarcoma. Semin Diagn Pathol. 2001; 18: 263–266.

Henricks W.H. , Chu Y.C. , Goldblum J.R. . Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997; 21: 271–281.

Kilpatrick S.E. , Doyon J. , Choong P.F. . The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 1996; 77: 1450–1458.

Downes K.A. , Goldblum J.R. , Montgomery E.A. . Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001; 14: 179–184.

Reitan J.B. , Kaalhus O. , Brennhovd I.O. . Prognostic factors in liposarcoma. Cancer. 1985; 55: 2482–2490.

Ehara S. , Rosenberg A.E. , Kattapuram S.V. . Atypical lipomas, liposarcomas and other fatcontaining sarcomas: CT analysis of the fat elements. Clin Imaging. 1995; 19: 50–53.

Evans H.L. . Liposarcomas and atypical lipomatous tumors: a study of 66 cases followed for a minimum of 10 years. Surg Pathol. 1988; 1: 41–54.

Jelinek J.S. , Kransdorf M.J. , Shmookler B.M. . Liposarcoma of the extremities: MR and CT finding in the histologic subtypes. Radiology. 1993; 186: 455–459.

Fletcher C.D. , Akerman M. , Dal Cin P. . Correlation between clin- icopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphologic (CHAMP) Collaborative Study Group. Am J Pathol. 1996; 148: 623–630.

Rubin B.P. , Fletcher C.D. . The cytogenetics of lipomatous tumours. Histopathology. 1997; 30: 507–511.

Suster S. , Fisher C. . Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol. 1997; 21: 195–200.

Dijkhuizen T. , Molenaar W.M. , Hoekstra H.J. . Cytogenetic analysis of a case of myxoid liposarcoma with cartilaginous differentiation. Cancer Genet Cytogenet. 1996; 92: 141–143.

Knight J.C. , Renwick P.J. , Cin P.D. . Translocation t(12;16)(q13;p11) in myxoid and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995; 55: 24–27.

Smith T.A. , Goldblum J.R. . Immunohistochemical analysis in myxoid/round cell liposarcoma of the extremities. Appl Immunohistochem. 1996; 4: 228–235.

Peterson J.J. , Kransdorf M.J. , Bancroft L.W. . Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol. 2003; 32: 493–503.

Kransdorf M.J. , Bancroft L.W. , Peterson J.J. . Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology. 2002; 224: 99–104.

Pearlstone D.B. , Pisters P.W. , Bold R.J. . Patterns of recurrence in extremity liposarcoma: implications for staging and followup. Cancer. 1999; 85: 85–92.

Cadman N.L. , Soule E.H. , Kelly P.J. . Synovial sarcoma: an analysis of 34 tumors. Cancer. 1965; 18: 613–627.

Cagle L.A. , Mirra J.M. , Storm F.K. . Histologic features relating to prognosis in synovial sarcoma. Cancer. 1987; 59: 1810–1814.

Goulouh R. , Vuzevski V. , Bracko M. . Synovial sarcoma: a clinicopathological study of 36 cases. J Surg Oncol. 1990; 45: 20–28.

Scully S.P. , Temple H.T. , Harrelson J.M. . Synovial sarcoma of the foot and ankle. Clin Orthop. 1999; 364: 220–226.

Miettinen M. , Virtanen I. . Synovial sarcoma: a misnomer. Am J Pathol. 1984; 117: 18–25.

Machen S.K. , Easley K.A. , Goldblum J.R. . Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial and poorly differentiated areas. Am J Surg Pathol. 1999; 23: 268–275.

Bergh P. , Meis-Kindblom J.M. , Gherlinzoni F. . Synovial sarcoma: identification of low and high risk groups. Cancer. 1999; 85: 2596–2607.

Fletcher J.A. , Kozakewich H.P. , Hoffer F.A. . Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 1991; 324: 436–442.

de Leeuw B. , Berger W. , Sinke R.J. . Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma specific t(X;18) (p11.2;q11.2) breakpoint. Genes Chromosomes Cancer. 1993; 6: 182–189.

Clark J. , Rocques P.J. , Crew A.J. . Identification of novel genes, SYT and SSX involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994; 7: 502–508.

Shipley J.M. , Clark J. , Crew A.J. . The t(X; 18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene. 1994; 9: 1447–1453.

Turc-Carel C. , Dal Cin P. , Limon J. . Involvement of chromosome X in primary cytogenetic change in human neoplasia: non-random translocation in synovial sarcoma. Proc NatlAcadSci U S A. 1987; 84: 1981–1985.

Barbashina V. , Benevenia J. , Aviv H. . Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases. J Cancer Res Clin Oncol. 2002; 128: 610–616. Epub 2002 Oct 29.

Singer S. , Baldini E.H. , Demitri G.D. . Synovial sarcoma: prognostic significance of tumor size, margin of resection and mitotic activity for survival. J Clin Oncol. 1996; 14: 1201–1208.

Jones B.C. , Sundaram M. , Kransdorf M.J. . Synovial sarcoma: imaging findings in 34 patients. AJR Am J Roentgenol. 1993; 161: 827–830.

Ariel I.M. . Tumors of the peripheral nervous system. CA Cancer J Clin. 1983; 33: 282–299.

Bojsen-Moller M. , Myhre-Jensen O. . A consecutive series of 30 malignant schwannomas: survival in relation to clinico-pathological parameters and treatment. Acta Pathol Microbiol Immunol Scand [A]. 1984; 92: 147–155.

Campanacci M. . Malignant peripheral nerve sheath tumors. In: Campanacci M. , ed. Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology, and Treatment. Wein: Springer-Verlag; 1999.

D'Agostino A.N. , Soule E.H. , Miller R.H. . Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (von-Recklinghausen's Disease). Cancer. 1963; 16: 1003–1014.

D'Agostino A.N. , Soule E.H. , Miller R.H. . Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (von Recklinghausen's disease). Cancer. 1963; 16: 1015–1027.

Enzinger F.W. , Weiss S.W. . Malignant tumors of peripheral nerves. In: Enzinger F.W. , Weiss S.W. , eds. Soft Tissue Tumors. St. Louis, Mo: CV Mosby Co; 1983.

Korf B.R. . Malignancy in neurofibromatosis type 1. Oncologist. 2000; 5: 477–485.

Donohue W.L. , Jaffe F.A. , Rewcastle N.B. . Radiation induced neurofibromata. Cancer. 1967; 20: 589–595.

Ducatman B.S. , Scheithauer B.W. . Post irradiation neurofibrosarcoma. Cancer. 1983; 51: 1028–1033.

Doorn P.F. , Molenaar W.M. , Buter J. . Malignant peripheral nerve sheath in patients with and without neurofibromatosis. Eur J Surg Oncol. 1995; 21: 78–82.

Poyhonen M. , Niemela S. , Herva R. . Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med. 1997; 121: 139–143.

Topsakal C. , Akdemir I. , Tiftikci M. . Malignant schwannoma of the sciatic nerve originating in a spinal plexiform neurofibroma associated with neurofibromatosis type 1: case report. Neurol Med Chir (Tokyo). 2001; 41: 551–555.

Weiss S.W. , Langloss J.M. , Enzinger F.M. . Value of S-l 00 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983; 49: 299–308.

Reynolds J.E. , Fletcher J.A. , Lytle C.H. . Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line. Hum Genet. 1992; 90: 450–456.

Rao U.N. , Surti U. , Hoffner L. . Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet Cytogenet. 1996; 88: 17–25.

Weiss SW. Leiomyosarcoma. In: Weiss S.W. , Goldblum J.R. , eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, Pa: Mosby; 2001.

Friedrich M. , Villena-Heinsen C. , Mink D. . Leiomyosarcomas of the female genital tract: a clinical and histopathological study. Eur J Gynaecol Oncol. 1998; 19: 470–475.

Gallup D.G. , Cordray D.R. . Leiomyosarcoma of the uterus: case reports and a review. Obstet Gynecol Surv. 1979; 34: 300–312.

Wang H.S. , Chen W.S. , Lin T.C. . Leiomyosarcoma of the rectum: a series of twelve cases. Zhonghua YiXue Za Zhi (Taipei). 1996; 57: 280–283.

Neugut A.I. , Sordillo P.P. . Leiomyosarcoma of the extremities. J Surg Oncol. 1989; 40: 65–67.

Campanacci M. . Leiomyosarcoma. In: Campanacci M. . Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology, and Treatment. Wein: Springer-Verlag; 1999.

Demers M.L. , Curley S.A. , Romsdahl M.M. . Inferior vena cava leiomyosarcoma. J Surg Oncol Suppl. 1992; 51: 89–92.

Farshid G. , Pradhan M. , Goldblum J. . Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol. 2002; 26: 14–24.

Gustafson P. , Willen H. , Baldetorp B. . Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer. 1992; 70: 114–119.

Nistal M. , Paniagua R. , Picazo M.L. . Granular changes in vascular leiomyosarcoma. Virchows Arch A Pathol Anat Histol. 1980; 386: 239–248.

Mankin H.J. , Casas-Ganem J. , Kim J.L. . Leiomyosarcoma of somatic soft tissues. Clin Orthop. 2004; 421: 225–231.

Aue G. , Hedges L.K. , Schwartz H.S. . Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlations. Cancer Genet Cytogenet. 1998; 105: 24–28.

Deenik W. , Mooi W.J. , Rutgers E.J. . Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer. 1999; 86: 969–975.

Montgomery E.A. , Meis J.M. , Ramos A.G. . Clear cell sarcoma of tendons and aponeuroses: a clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol. 1993; 1: 89–100.

Lucas D.R. , Nascimento A.G. , Sim F.H. . Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992; 16: 1197–1204.

Eckardt J.J. , Pritchard D.J. , Soule E.H. . Clear cell sarcoma: a clini- copathologic study of 27 cases. Cancer. 1983; 52: 1482–1488.

Rodriquez E. , Sreekantaiah C. , Reuter V.E. . t(12;22)(q13;q13) and trisomy 8 are non-random aberrations in clear cell sarcoma. Cancer Genet Cytogenet. 1992; 64: 107–110.

Scott S.M. , Reiman H.M. , Pritchard D.J. . Soft tissue fibrosarcoma: a clinicopathologic study of 132 cases. Cancer. 1989; 64: 925–931.

Chow L.T. , Lui Y.H. , Kumta S.M. . Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature. J Clin Pathol. 2004; 57: 90–94.

Papagelopoulos P.J. , Galanis E.C. , Trantafyllidis P. . Clinicopathologic features, diagnosis and treatment of fibrosarcoma of bone. Am J Orthop. 2002; 31: 253–257.

Smith S.E. , Kransdorf M.J. . Primary musculoskeletal tumors of fibrous origin. Semin Musculoskelet Radiol. 2000; 4: 73–88.

Coffin C.M. , Dehner L.P. , Meis-Kindblom J.M. . Inflammatory myofi- broblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations Semin Diagn Pathol. 1998; 15: 102–110.

Testini M. , Caputiiambrenghi O. , Ettorre G.C. . Fibrosarcoma of the thigh: case report and review of the literature. Panminerva Med. 1996; 38: 51–55.

O'Sullivan M.J. , Sirgi K.E. , Dehner L.P. . Low grade fibrosarcoma (hyalinizing spindle cell tumor with giant rosettes) with pulmonary metastases at presentation: case report and review of the literature. J Surg Pathol. 2002; 10: 211–216.

Ferguson W.S. . Advances in the adjuvant treatment of infantile fibrosarcoma. Expert Rev Anticancer Ther. 2003; 3: 185–191.

Cecchetto G. , Carli M. , Alaggio R. . Fibrosarcoma in pediatric patients: results of the Italian Cooperative Group studies (1979-1995). J Surg Oncol. 2001; 78: 225–231.

La Quaglia M.P. , Heller G. , Ghavimi F. . The effect of age at diagnosis on outcome in rhabdomyosarcoma. Cancer. 1994; 73: 109–117.

Lundgren L. , Angervall L. , Stenman G. . Infantile rhabdomyosarcoma: a high grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma. Hum Pathol. 1993; 24: 785–795.

Pappo A.S. , Shapiro D.N. , Crist W.M. . Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 1995; 13: 2123–2139.

Kodet R. , Newton W.A. , Sachs N. . Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled in the Intergroup Rhabdomyosarcoma Study. Hum Pathol. 1991; 22: 674–684.

Heyn R. , Beltangady M. , Hays D. . Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1989; 7: 200–207.

Raney R.B. , Anderson J.R. , Barr F.G. . Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 2001; 23: 215–220.

Kilpatrick S.E. , Teot L.A. , Geisinger K.R. . Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma: comparison of flow cytometry and image analysis. Cancer. 1994; 74: 3227–3233.

Halling A.C. , Wollan P.C. , Pritchard D.J. . Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc. 1996; 71: 636–642.

Matsushita Y. , Ahmed A.R. , Kawaguchi N. . Epithelioid sarcoma of the extremities: a dismal long-term outcome. J Orthop Sci. 2002; 7: 462–466.

Chase D.R. , Enzinger F.M. . Epithelioid sarcoma: diagnosis, prognostic indicators, and treatment. Am J Surg Pathol. 1985; 9: 241–263.

Evans H.L. , Baer S.C. . Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin Diagn Pathol. 1993; 10: 286–291.

Halling A.C. , Wollan P.C. , Pritchard D.J. . Epithelioid sarcoma: a clinicopathologic review of 56 cases. Mayo Clin Proc. 1996; 71: 636–642.

Miettinen M. , Fanburg-Smith J.C. , Virolainen M. . Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999; 30: 934–942.

Steinberg B.D. , Gelberman R.H. , Mankin H.J. . Epithelioid sarcoma in the upper extremity. J Bone Joint Surg Am. 1992; 74: 28–35.

Sugarbaker P.H. , Auda S. , Webber B.L. . Early distant metastases from epithelioid sarcoma of the hand. Cancer. 1981; 48: 852–855.

Auerbach He , Brooks J.J. . Alveolar soft part sarcoma: a clinicopathologic and immunohistochemical study. Cancer. 1987; 60: 66–73.

Nakano H. . Alveolar soft part sarcoma: histogenesis. Anticancer Res. 1998; 18: 4207–4211.

Pang L.M. , Roebuck D.J. , Griffith J.F. . Alveolar soft-part sarcoma: a rare soft tissue malignancy with distinctive clinical and radiological features. Pediatr Radiol. 2001; 31: 196–199.

Ordonez N.G. . Alveolar soft part sarcoma: a review and update. Adv Anat Pathol. 1999; 6: 125–139.

Craver R.D. , Heinrich S.D. , Correa H. . Trisomy 8 in alveolar soft part sarcoma. Cancer Genet Cytogenet. 1995; 81: 94–96.

Heimann P. , Devalck C. , Debusscher C. . Alveolar soft-part sarcoma: further evidence by FISH for the involvement of chromosome band 17q25. Genes Chromosomes Cancer. 1998; 23: 194–197.

Tornoczky T. , Kalman E. , Sapi Z. . Cytogenetic abnormalities of alveolar soft-part sarcomas using interphase fluorescent in situ hybridization: trisomy for chromosome 7 and monosomy for chromosomes 8 and 18 seem to be characteristic of the tumor. Virchows Arch. 2001; 438: 173–180.

Temple H.T. , Scully S.P. , O'Keefe R.J. . Clinical presentation of alveolar soft-part sarcoma. Clin Orthop. 1994; 300: 213–218.

van Ruth S. , van Coevorden F. , Peterse J.L. . Alveolar soft-part sarcoma: a report of 15 cases. Eur J Cancer. 2002; 38: 1324–1328.

Reichardt P. , Lindner T. , Pink D. . Chemotherapy in alveolar softpart sarcomas: what do we know? Eur J Cancer. 2003; 39: 1511–1516.

Meis-Kindblom J.M. , Kindblom L.G. . Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998; 22: 683–697.

Naka N. , Ohsawa M. , Tomita Y. . Angiosarcoma in Japan: a review of 99 cases. Cancer. 1995; 75: 989–996.

Naka N. , Ohsawa M. , Tomita Y. . Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996; 61: 170–176.

Chor P.J. , Santa Cruz D.J. . Kaposi's sarcoma: a clinicopathologic review and differential diagnosis. J Cutan Pathol. 1992; 19: 6–20.

Krown S.E. . Acquired immunodeficiency syndrome-associated Kaposi's sarcoma: biology and management. Med Clin North Am. 1997; 81: 471–494.

Weiss R.A. , Whitby D. , Talbot S. . Human herpesvirus type 8 and Kaposi's sarcoma. J Natl Cancer Inst Monogr. 1998; 23: 51–54.

Amendola B.E. , Amendola M.A. , McClatchey K.D. . Radiation associated sarcoma: a review of 23 patients with postradiation sarcoma over a 50-year period. Am J Clin Oncol. 1989; 12: 411–415.

Laskin W.B. , Silverman T.A. , Enzinger F.M. . Post radiation soft tissue sarcomas: an analysis of 53 cases. Cancer. 1988; 62: 2330–2340.

Chen K.T. , Hoffman K.D. , Hendricks E.J. . Angiosarcoma following therapeutic irradiation. Cancer. 1979; 44: 2044–2048.

Moser R.P. , Parrish W.M. . Radiologic evaluation of soft tissue tumors. In: Weiss S.W. , Goldblum J.R. , eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, Pa: Mosby; 2001.

Berquist T.H. , Ehman R.I. , King B.F. . Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR Am J Roentgenol. 1990; 155: 1251–1255.

Dalinka M.K. , Zlatkin M.B. , Chao P. . The use of magnetic resonance imaging in the evaluation of bone and soft-tissue tumors. Radiol Clin North Am. 1990; 28: 461–470.

Ma L.D. , Frassica F.J. , McCarthy E.F. . Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Radiology. 1997; 202: 739–744.

Arkun R. , Memis A. , Akalin T. . Liposarcoma of soft tissue: MRI findings with pathologic correlation. Skeletal Radiol. 1997; 26: 167–172.

Szklaruk J. , Tamm E.P. , Choi H. . MR imaging of common and uncommon large pelvic masses. Radiographics. 2003; 23: 403–424.

Bancroft L.W. , Peterson J.J. , Kransdorf M.J. . Soft tissue tumors of the lower extremities. Radiol Clin North Amer. 2002; 40: 991–1011.

Bastinaannet E. , Groen H. , Jager P.L. . The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas: a systematic review and meta-analysis. Cancer Treat Rev. 2004; 30: 83–101.

Israel-Mardirosian N. , Adler L.P. . Positron emission tomography of soft tissue sarcomas. Curr Opin Oncol. 2003; 15: 327–330.

Mankin H.J. , Mankin Cj , Simon M.A. . The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996; 78: 656–663.

Mankin H.J. , Fondren G. , Hornicek F.J. . The use of flow cytometry in assessing malignancy in bone and soft tissue tumors. Clin Orthop. 2002; 397: 95–105.

Hau A. , Kim I. , Kattapuram S. . Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol. 2002; 31: 349–353.

Geisinger K.R. , Abdul-Karim F.W. . Fine needle aspiration biopsies of soft tissue tumors. In: Weiss S.W. , Goldblum J.R. , eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, Pa: Mosby; 2001.

Liu K. , Layfield L.J. , Coogan A.C. . Diagnostic accuracy in fine- needle aspiration of soft tissue and bone lesions: influence of clinical history and experience. Amer J Clin Pathol. 1999; 111: 632–640.

Kilpatrick S.E. , Ward W.G. , Cappellari J.O. . Fine-needle aspiration biopsy of soft tissue sarcomas: a cytomorphologic analysis with emphasis on histologic subtyping, grading and therapeutic significance. Am J Clin Pathol. 1999; 112: 179–188.

Karakousis C.P. , Emrich L.J. , Vesper D.S. . Soft-tissue sarcomas of the proximal lower extremity. Arch Surg. 1989; 124: 1297–1300.

Sugarbaker P.H. . Surgical techniques for extremity soft tissue sarcomas. In: Raaf J.H. , ed. Soft Tissue Sarcomas: Diagnosis and Treatment. St. Louis, Mo: Mosby; 1993.

Simon M.A. , Enneking W.F. . The management of soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1976; 58: 317–327.

Enneking W.F. . A system of staging musculoskeletal neoplasm. Clin Orthop. 1986; 204: 9–24.

American Joint Cancer Conference Cancer Staging Manual. American Joint Committee on Cancer. 5th ed. Philadelphia, Pa: Lippin- cott-Raven; 1997.

Heslin M.J. , Woodruff J. , Brennan M.F. . Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: implications for management. J Clin Oncol. 1996; 14: 473–478.

van Doorn R.C. , Gallee M.P. , Hart A.A. . Resectable retroperitoneal soft tissue sarcomas: the effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer. 1994; 73: 637–642.

Grobmyer S.R. , Brennan M.F. . Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003; 15: 319–326.

O'Sullivan B. , Wylie J. , Catton C. . The local management of soft tissue sarcomas. Semin Radiat Oncol. 1999; 9: 328–348.

Refaat Y. , Gunnoe J. , Hornicek F.J. . Comparison of quality of life after amputation or limb salvage. Clin Orthop. 2002; 397: 298–305.

Willard W.C. , Hajdu S.I. , Casper E.S. . Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg. 1992; 215: 269–275.

Suit H.D. , Spiro I. . Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol. 1994; 10: 347–356.

Suit H.D. , Mankin H.J. , Wood W.C. . Treatment of the patient with stage M0 soft sarcoma. J Clin Oncol. 1988; 60: 854–862.

Suit H.D. , Mankin H.J. , Wood W.C. . Pre- and postoperative chemotherapy. In: Raaf J.H. , ed. Soft Tissue Sarcomas: Diagnosis and Treatment. St. Louis, Mo: Mosby; 1993.

DeLaney T.F. , Rosenberg A.E. , Harmon D.C. . Soft Tissue Sarcomas. In: Price P. , Sikora K. , eds. Treatment of Cancer. 4th ed. New York, NY: Oxford University Press; 2002.

Suit H.D. , Mankin H.J. , Wood W.C. . Preoperative, intraoperative and postoperative radiation in the treatment of soft tissue sarcoma. Cancer. 1985; 55: 2659–2667.

Suit H.D. , Mankin H.J. , Wood W.C. . Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol. 1988; 6: 854–862.

Willett CG; Schiller A.L. , Suit H.D. . The histologic response of soft tissue sarcoma to radiation therapy. Cancer. 1987; 60: 1500–1504.

Levine E.A. , Trippon M. , Das Gupta T.K. . Preoperative multimodality treatment for soft tissue sarcomas. Cancer. 1993; 71: 3685–3689.

Clarke D.H. , Martinez A. . An overview of brachytherapy in cancer management. Oncology (Huntingt). 1990; 46: 51–52, 54.

Schray M.F. , Gunderson L.L. , Sim F.H. . Soft tissue sarcoma: integration of brachytherapy, resection and external irradiation. Cancer. 1990; 66: 451–456.

Willett C.G. , Suit H.D. , Tepper J.E. . Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer. 1991; 68: 278–283.

Suit H.D. , Rosenberg A.E. , Harmon D.C. . Soft tissue sarcomas. In: Sikora K. , Halnan K.E. , eds. Treatment of Cancer. 2nd ed. London: Chapman and Hall Medical; New York, NY: Van Nostrand Reinhold; 1990.

Brennan M.F. , Casper E.S. , Harrison L.B. . The role of multimodality therapy in soft-tissue sarcoma. Ann Surg 1991; 214: 328–338.

Han P. , Drachtman R.A. , Amenta P. . Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide. J Pediatr Hematol Oncol. 1996; 18: 314–317.

Hawkins R.E. , Wiltshaw E. , Mansi J.L. . Ifosfamide with and without adriamycin in advanced uterine leiomyosarcoma. Cancer Chemother Pharmacol. 1990; 26(suppl): S26–S29.

Rosenberg S.A. , Kent H. , Costa J. . Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery. 1978; 84: 62–69.

Rosenberg S.A. , Tepper J. , Glatstein E. . Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983; 52: 424–434.

Eilber F.R. , Morton D.L. , Eckardt J. . Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer. 1984; 53: 2579–2584.

Blum R.H. , Corson J.M. , Wilson R.E. . Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin and DTIC (CAD). Cancer. 1980; 46: 1722–1726.

Steins M.B. , Serve H. , Zuhlsdorf M. . Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy. Oncol Rep. 2002; 9: 627–630.

Scaife C.L. , Pisters P.W. . Combined-modality treatment of localized soft tissue sarcomas of the extremities. Surg Oncol Clin N Amer. 2003; 12: 355–368.

Patel S.R. . Recent advances in the systemic therapy of soft tissue sarcomas. Expert Rev Anticancer Ther. 2003; 3: 179–184.

Reichardt P. . High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol. 2002; 41: 157–167.

Picci P. . Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults. Curr Oncol Rep. 2000; 2: 502–507.

DeLaney T.F. , Spiro I.J. , Suit H.D. . Neoadjuvant chemotherapy and radiotherapy for large extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003; 56: 1117–1127.

Zeytoonjian T. , Mankin H.J. , Gebhardt M.C. . Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int. 2004; 25: 325–330.